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Abstract

Introduction

Urinary glycosaminoglycans are selectively included
into calcium oxalate (CaOx) crystals precipitated from
whole human urine: The presence of glycosaminoglycans (GAGs) in the organic matrix of urinary stones,
and their known effects on CaOx crystallization have
prompted speculation regarding their role in CaOx urolithiasis. The aim of this study was to examine the
involvement of GAGs in the early stages of CaOx crystallization in human urine. Urine samples were collected from healthy men and CaOx crystallization was induced by the addition of a sodium oxalate load. The
crystals were harvested and demineralized, and the GAG
content of the resulting extract analysed by cellulose
acetate electrophoresis. Only one GAG, heparan sulphate (HS) was detected in the organic matrix of the
crystals; chondroitin sulphate (ChS), the most abundant
urinary GAG, was conspicuously absent. Further experiments, in which varying amounts of HS and ChS were
added to ultrafiltered (10,000 Da) urine prior to induction of calcium oxalate crystallization, showed that ChS
was included into the crystals only when HS was absent
from the urine. It was concluded that the selective inclusion of GAGs into crystals and stones is a function
related more to relative binding affinity than to ambient
GAG concentration and that HS and ChS compete for
specific binding sites on the crystal surface.

All urinary stones, regardless of their mineral content, contain a network of organic matrix that is distributed throughout their crystalline structure and accounts
for 2-6% of their total weight [5, 27, 31]. Because its
presence would suggest that it may fulfil some directive
function in the stone's formation, many years of research have been devoted to its study. However, its role
remains enigmatic, largely because early workers were
unable to dissolve 75 % of the lyophilized stone matrix,
and this seriously hampered attempts to characterize its
component macromolecules [6]. Nonetheless, study of
the 25 % of matrix which they could dissolve yielded
some information which at least provided a clue as to
which macromolecules may be involved in a stone's formation. The major portion of matrix consists of protein
[4], with the remainder comprising an ill-defined mixture of various materials ranging from "inorganic ash"
to bacteria and cellular membranes [12]. More recently,
a second class of macromolecules, the glycosaminoglycans (GAGs), have also been detected in matrix [16, 19]
and these are worthy of particular scrutiny because a
number of studies have demonstrated that some of them
are inhibitors of calcium oxalate (CaOx) crystallization
in aqueous inorganic media [3, 7, 10, 17, 20, 21, 22,
25].
Although a recent study [34] found that the only
GAG in CaOx stone matrix was heparan sulphate (HS),
others have previously reported [16] that CaOx dihydrate
stones contain two GA Gs, namely, HS and hyaluronic
acid (HA), a finding confirmed by Roberts and Resnick
[ 19], who also demonstrated the presence of these GAGs
both in CaOx monohydrate stones and in those containing calcium phosphate. Perhaps, the most intriguing
aspect of these studies is that though both HS and HA
occur in normal human urine, they are minor constituents: HA is present in only trace amounts, while HS
accounts for some 15-20% of the total GAG complement
[13, 30, 32]. Chondroitin sulphate (CS), on the other
hand, comprises approximately 60% of urinary GAGs
[13, 30, 32], but though present in small amounts in
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both magnesium ammonium phosphate [19) and apatite
stones [16), it has not been detected in CaOx stone matrix [16, 19, 34). The findings of Nishio et al. [16),
Roberts and Resnick [19) and Yamaguchi et al. [34) indicate that the inclusion of GAGs into kidney stone matrix does not simply reflect their proportional representation in human urine. Though this discrepancy may be
attributable to the relative binding affinities of each
GAG for the CaOx crystal surface [l, 11), equally, it
may be the consequence of a number of other factors,
including difficulties with dissolving matrix, as discussed
above. Furthermore, identification of matrix GAGs
like proteins, has been frustrated by the fact that thei;
molecular structure and properties can be altered by the
aggressive procedures required for their isolation from
the stone, ageing, polymerization and their very involvement in the crystallization process [9, 14, 18). To these
can be added a further complicating factor: macromolecules in matrix can derive both from the normal urinary
complement and from endothelial trauma caused by the
inchoate or developed stone during its passage through
the renal collecting system and urinary tract [9]. It is
possible therefore, that GAGs may be present in matrix
as a result of the participation of normal urinary GAGs
in the crystallization of CaOx, the binding to crystal
surfaces of GAGs released by tissue damage, that are
not normally present in urine, or both.
Collectively, these problems have conspired to obscure the role of urinary GAGs in stone pathogenesis.
However, to a large extent the problems associated with
the analysis of GAGs in renal stones can be overcome
by studying those included in CaOx crystals freshly precipitated from human urine, an approach which has been
successfully adopted for studying the involvement of urinary proteins in CaOx crystallization [9, 19). The aim
of this study was therefore to determine which urinary
GAGs are involved in the formation of CaOx crystals
newly deposited from fresh human urine.

Collection and preparation of urine samples

Twenty four hour urine specimens, refrigerated
throughout the collection period, were obtained without
preservative from 5 healthy men aged between 30 and
43 years. Each specimen was tested to exclude the presence of blood using Multistix test strips (Miles Laboratories, Mulgrave, Victoria, Australia). The samples
were then pooled and subjected to one of the following
treatments. Whole urine (WU) was obtained by passing
the urine through a 20-µm pore-size nylon mesh (Swiss
Screens; Sydney, Australia; Nytal HD20) to remove cellular debris. Spun and filtered urines (SF) were prepared by centrifugation at 10,000 x g for 30 minutes in
a J2-21M/E centrifuge (Beckman Instruments, Palo Alto,
CA), followed by filtration through 0.22-µm pore-size
filters (GSWP04700; Millipore Corp; Bedford, MA),
while ultrafiltered urines (UF) were similarly treated
prior to ultrafiltration using a hollow fibre bundle
(HlPl0-20; Amicon Corp, Danvers, MA) with a nominal molecular mass cut-off of 10 kDa. Urine samples
were refrigerated until required and warmed to 37°C
immediately prior to use.
Induction of CaOx crystallimtion

Preparation of CaOx crystals from urine and isolation of their organic matrix were performed as described
by Doyle et al. [9], with the urinary metastable limit
being determined using a modification [28) of the original method of Ryall et al. [24). Thirty mmol/1 of sodium oxalate, in excess of the measured metastable limit,
was added drop-wise to the urine and the specimen was
incubated in a shaking water bath at 37°C for 1 hour.
To increase the yield of CaOx crystals, the same amount
of oxalate was added after 1 hour, and again after 2
hours. The reaction was carried out for a total of 3
hours.
In the initial experiments, HS and ChS were added
to ultrafiltered urine at final concentrations of 1, 2 and
10 µglml respectively.

Materials and Methods
Materials

Isolation of crystal matrix

All reagents were of analytical purity. Unless stated
otherwise, the biochemicals were purchased from the
suppliers listed in a previous paper [9]. Chondroitin
sulphate, heparan sulphate, chondroitinase ABC (EC
4.2.2.4), heparitinase (EC 4.2.2.8) and D-glucuronic
acid were obtained from Sigma Chemical Co., St.
Louis, MO). All solutions were prepared with the highest quality water from a "Hi Pure" water purification
system fitted with a 0.2 µm pore-size filter (Permutit
Australia, Brookvale, NSW, Australia). Cellulose acetate strips (Sepraphore III, 2.5 x 15.2 cm) were obtained
from Gelman Sciences (Ann Arbor, MI, USA) and
stained with Alcian blue (Sigma).

Crystals precipitated from the UF urines were isolated by 0.22 µm Millipore filtration. However, those
deposited from the WU specimens were removed by
centrifugation at 10,000 x g for 20 minutes in a Beckman J2-21M/E centrifuge, because whole human urine
cannot be filtered [8, 33) owing to the presence of polymerized Tamm-Horsfall glycoprotein (THG). The crystals were then washed with 0.1 mol/1 NaOH and distilled
water to remove any glycosaminoglycans present in the
small amounts of residual urine associated with the crystals. This step was repeated 6 times prior to their demineralization in 0.25 mol/1 ethylenediarninetetraacetic
524
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Table l. Concentrations of HS and ChS added to
samples on the same ultrafiltered urine.

acid (EDTA) solution (pH 8.0) for three days at 4°C as
described in detail by Doyle et al. [9]. Following exhaustive electrodialysis to remove the EDT A, the demineralized crystal extracts were lyophilized to yield a
colourless, flocculant material that was processed as
described below.

(HS) µ,g/ml

Electrophoresis

(ChS) µg/ml

After dissolution of the lyophilized extract (20 µgl
20 µI of distilled water), 2-5 µI was applied to cellulose
acetate strips and electrophoresed for 90 minutes in 0.2
mol/1 of pH 7.2 calcium acetate buffer [29] at a constant
voltage of 80 V). HS and ChS were run simultaneously
as standards at a concentration of 1 µ,g/µl. After electrophoresis, the cellulose acetate strips were stained for
30 minutes in 0.2 % Alcian blue in 25 mmol/1 sodium
acetate buffer (pH 5.8), containing 50 mmol/1 magnesium chloride and 50 % ethanol. The membrane was then
destained in several changes of the same buffer.
GAGs were provisionally identified by comparing
the bands on the electrophoretogram with the migration
distances of the standards included in each run. Identification was confirmed by digesting the matrix solution,
prior to electrophoresis, with chondroitinase and heparitinase. Samples of crystal matrix were incubated with
chondroitinase ABC (0.5 unit of enzyme/100 µg uronic
acid) in 0.1 mol/1 Tris-RC! buffer (pH 8.0) at 37°C for
18 hours, or with heparitinase (2 units of enzyme/100 µg
uronic acid) in acetate buffer (pH 6. 7) at 43 °C for 60
minutes. Total GAG was estimated by determining
uronic acid concentration using the method of Blumenkrantz and Asboe-Hansen [2] using D-glucuronic acid as
standard.
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crystal formation induced, the electrophoretogram of the
resulting crystal extract showed the presence of the same
band as was observed with the extract derived from the
SF urine.
Because these results indicated that heparan sulphate
is selectively included into CaOx crystals to the exclusion of other urinary GAGs, a further experiment was
carried out where CaOx crystals were precipitated from
UF urine which had been supplemented with ChS at a
final concentration of 10 µg/ml. In this case, the electrophoretogram demonstrated the presence of a weakly
staining band that had the same migration characteristics
of ChS. This band disappeared after digestion with
chondroitinase, but not with heparitinase, confirming
that it was chondroitin sulphate.
Since this result provided further evidence that the
inclusion of GAGs into CaOx crystals is selective, and
suggested that binding of urinary GAGs to the crystal
surface is competitive, an additional experiment was undertaken in which increasing concentrations of HS and
ChS were added to samples of the same ultrafiltered
urine in a grid construction as shown in Table 1. Crystallization was induced by the addition of oxalate as before, and after isolation of the matrix extract from the
CaOx crystals precipitated from each of the 16 urine
samples, the lyophilized materials were dissolved and
electrophoresed. The electrophoretograms are shown in
Figure 2. In the absence of any added GAGs, and at
ChS and HS concentrations of O and 1 µg/rnl, respectively, no bands were visible. ChS was detected in the
crystal extract only at a final urinary concentration of 10
µglml, and then, only in the complete absence of HS or
in the presence of the lowest concentration of HS tested
(1 µg/ml), where a faint band was visible. In contrast,
HS was visible in the extract at a concentration of 1
µglml in the presence of ChS concentrations of 1 and 2
µg/ml, and was always observed at higher concentrations. Although the results were not quantified, it is
apparent that the amount of HS incorporated into the
crystals decreased in relation to increasing concentrations
of ChS. This effect is most noticeable at an HS concentration of 2 µg/ml. The competition between ChS and

Results
In all cases, calcium oxalate monohydrate crystals
were precipitated. Figure 1 shows electrophoretograms
of HS and ChS standards, matrix extract of CaOx crystals precipitated from whole urine (WU), centrifuged
and filtered urine (S&F) and ultrafiltered urine to which
HS (UF+HS) and ChS (UF+ChS) had been added;
bands are shown before and after heparitinase digestion.
Only one band was visible in the matrix from the whole
(WU) and spun and filtered (SF) urines. The band was
identified as HS, since its migration distance was identical to that of standard HS, and it disappeared after digestion with heparitinase. It was unaffected by papain
digestion, suggesting that the HS in the crystals was not
present as a proteoglycan.
As expected, no GAG bands were detected in electrophoretograms of the matrix of CaOx crystals deposited from UF urines. However, when HS was added to
UF urine at a final concentration of 2 µg/ml, and CaOx
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Figure 1. Cellulose acetate electrophoretograms of standards and GAGs extracted from CaOx crystals precipitated from
urine, before (a) and after (b) digestion with heparitinase: HS, heparan sulphate standard (1 µg/µl); WU, extract of
crystals deposited from whole (untreated) human urine; S&F, extract of crystals obtained from urine that had been
centrifuged and filtered; UF + HS, crystal extract derived from ultrafiltered urine to which HS had been added at a
final concentration of 2 µglml; UF + ChS, extract of crystals precipitated from ultrafiltered urine that had been
supplemented with ChS at a final concentration of 10 µglml; ChS, chondroitin sulphate standard (2 µg/µI). No bands
were visible in extracts of crystals generated in ultrafiltered urine.
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Figure 2. Cellulose acetate electrophoretograms of extracts of CaOx crystals precipitated from ultrafiltered urine
supplemented with varying concentrations of ChS and HS. The concentrations refer to the final concentrations of GAGs
added to the ultrafiltered urine. Standards are included for comparison (HS, 1 µglml; ChS, 2 µg/ml) as well as the
electrophoretogram for the extract of the same urine which had been centrifuged and filtered only, and which contained
no supplementary ChS or HS.

HS can also be seen at an HS concentration of 1 µg/ml
in the presence of 10 µglml ChS, where the 10-fold
greater concentration of the latter appears to have prevented the inclusion of HS, which was observed at lower
concentrations of ChS.

Crystals precipitated from the same urine which had
been spun and filtered, but not ultrafiltered, contained
only HS, confirming the findings of the first part of this
study.
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HA, and similar results were later reported for CaOx
monohydrate stones [19] although more recent findings
[34] showed that HA is not present in stones. Thus,
even if GAGs are released into urine in response to urothelial trauma, their qualitative incorporation into stones
is identical to that into freshly deposited crystals, indicating that their presence in matrix is more a function of
selectivity than of quantity. This selectivity can be ascribed to the fact that different GAGs possess different
binding affinities for the CaOx crystal surface. Fellstrom et al. [11] measured the relative binding affinities
of a number of GAGs to calcium oxalate crystals in inorganic media and reported that, in addition to ionic
strength, the binding affinity of each GAG was directly
related to its charge density in the order: pentosan
polysulphate (a synthetic GAG) > heparin (not present
in human urine) > ChS. They also demonstrated that
the inhibitory potency of these GAGs decreased in the
same order [10], and concluded that the inhibitory activity of GAGs is largely a function of their charge density.
Later, Angell and Resnick [1] also showed that GAGs
differ in their binding affinity for CaOx, but obtained
different results: heparin > HA > ChS > pentosan
polysulphate. The discrepancy in the order of binding
affinity may perhaps result from differences in methodology used. Nonetheless, both studies confirm that different GAGs do not bind with equal strength and this may
explain the selective incorporation of HS into stones and
CaOx crystals at the expense of ChS.
It is noteworthy that the selectivity of GAGs inclusion into stones, observed independently by three different research groups and now confirmed in this study using CaOx crystals, was ascribed to completely opposite
causes. The fact that ChS could not be detected in stone
matrix, coupled with earlier observations that it inhibits
CaOx crystallization, prompted Nishio et al. [16] to conclude that HS and HA, which were present in the matrix, must be promoters of stone formation. Paradoxically however, Roberts and Resnick [19] on the basis of
identical findings, suggested the contrary interpretation.
They attributed the presence of HS and HA in stone matrix to their strong binding affinity for the surface of the
crystals comprising the stone, and since it is generally
accepted that the magnitude of an inhibitor's effect is a
function of the efficiency of its binding to the crystal
surface, they implied in their discussion that HS and HA
normally fulfil an inhibitory role in urine. Yamaguchi
et al. [34] arrived at the same conclusion; they inferred
from their results that HS strongly inhibits CaOx crystal
growth and aggregation, since HS was the only GAG
present in soluble stone and crystal matrices, which exhibited strong inhibitory effects in their study. More recent!y, however, evidence has been obtained that urinary
GAGs can exert a dual effect on CaOx crystallization,

Discussion
More than twenty years have elapsed since Crawford et al. [7] showed that the crystallization of calcium
oxalate (CaOx) is inhibited by synthetic and natural
GAGs. Their observation, and the fact that GAGs occur
naturally in urine, have since prompted numerous workers to investigate the possibility that these molecules may
play a determinant role in stone pathogenesis. This possibility was later strengthened by the detection of GAGs
in urinary stones [16, 19, 34], but was confused somewhat by the observation of a mismatch between the relative amounts of specific GAGs in urine and calculi. The
GAGs present in CaOx stones, HS and HA [16, 19, 34],
are only minor urinary constituents, while the most
abundant urinary GAG, ChS, has not been detected in
stone matrix. One explanation for this discrepancy is
that matrix GAGs, like proteins [9], may possibly derive
from two distinct sources. First, normal urinary GAGs
may bind to the surface of newly formed crystals in the
renal collecting system; provided the urine remains sufficiently supersaturated, they will then become embedded
within the crystal architecture as new mineral is deposited upon the crystal surface. Second, it is possible that
once crystals have formed, their very presence in the
urinary tract may alter the GAG content of urine by
damaging the urothelium and causing the release of
GAGs in relative quantities quite different from their
normal proportional complement in urine. These GAGs
may now bind to the surface of the crystals, and as stone
development occurs, these too will become incorporated
within the stone structure. It is possible therefore that,
despite its low concentration in urine, HS may be present in stones because large amounts of it are released in
response to urothelial injury, not because it plays some
active role in the precipitation of CaOx crystals from
urine. It is important to distinguish between the two
mechanisms of GAGs inclusion because in one case the
GAGs may have contributed to the formation of the calculus, while in the other they are a product of it.
In the present study, the complicating factor of
GAGs derived from tissue trauma was avoided by studying the GAG component of CaOx crystals freshly precipitated from human urine, an approach that has been
successfully adopted to study the role of urinary proteins
in matrix [9, 15]. It was found that GAGs are present
in CaOx crystals even when precipitation takes place in
the presence of other urinary macromolecular competitors such as proteins, suggesting that binding takes place
on specific sites on the crystalline surfaces. Only one
urinary GAG, HS, was included into the crystals.
GAGs in CaOx crystals are therefore identical to those
in CaOx stones: Nishio et al. [16] showed that the soluble matrix of CaOx dihydrate stones contained HS and
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urine. However, this is doubtful in view of the fact that
ChS does not affect CaOx crystallization in undiluted,
ultrafiltered human urine [23) at a final concentration of
20 µglml, a concentration double that used in the present
study.
In summary therefore, the present study has demonstrated that urinary GAGs are involved in the critical
crystallization stage of stone formation. The inclusion
of GAGs into CaOx crystals precipitated from undiluted
human urine is a selective process and, as with urinary
stones, HS is incorporated in preference to ChS, despite
the fact that ChS is present in urine at a concentration
approximately 4 times greater than that of HS [13, 30,
32). Furthermore, even if a proportion of GAGs in
stones is derived from those released into urine as a result of tissue damage caused by the stones themselves,
it is apparent that only HS binds strongly enough to be
included in the fully developed structure. The routine
measurement of total urinary GAGs excretion is therefore unlikely to be of any practical benefit in the diagnosis and management of urolithiasis, a point made previously by Fellstrom et al. [10). However, the mere
presence of HS in kidney stones does not presuppose a
critical function for it in calculus formation; it may simply be a passive adsorbent that binds non-specifically to
the inorganic crystal phase, rather than an active protagonist in the crystallization process. Furthermore, even
if the involvement of HS in the crucial crystallization
stage of stone formation is directive, paradoxically, it
may be either as an inhibitor or promoter. Future studies should therefore be aimed at determining whether the
presence of HS in crystals and stones is a consequence
of its acting as an inhibitor or promoter of CaOx crystallization, or whether it is simply a disinterested participant in the process.

promoting crystal nucleation, while at the same time reducing the final size of the crystals produced. Thus,
Shum and Gobel [26) showed that, at the same uronic
acid concentration, both ChS and HS enhanced CaOx
nucleation from frozen ultrafiltered urine, whereas only
HS derived from controls exhibited the effect. Similarly, they reported that crystals precipitated from frozen
ultrafiltered urine samples to which HS had been added
were smaller than those deposited in the presence of
ChS, irrespective of whether the GAGs were isolated
from stone formers or controls. Those findings are consistent with those reported here. The greater inhibitory
effect of HS is not unexpected, since it bears structural
similarities to heparin [10, 11), unlike ChS, which has
no measurable effect on CaOx crystallization in ultrafiltered, undiluted human urine [23). Moreover, it can be
argued that enhancement of crystal nucleation can be
beneficial, since it is well recognised that rapid nucleation gives rise to smaller crystals; such crystals would be
more easily and quickly flushed from the urinary tract
and thereby reduce the probability of crystal retention
and stone formation.
In addition to demonstrating that the inclusion of
urinary GAGs into CaOx crystals is a selective phenomenon, the present study also represents the first attempt
to examine the relative binding affinities of HS and ChS
in undiluted human urine, a medium in which their binding properties are more likely to reflect their binding
properties in vivo. This was done by systematically increasing the relative amounts of HS and ChS added to
ultrafiltered urine before inducing CaOx crystallization.
The data indicated that when binding does occur, the
amount of GAG bound is directly proportional to the
ambient concentration; for instance, although not quantified, it was apparent that the amount of HS incorporated
into the crystals increased in response to increasing concentrations of exogenous HS in the ultrafiltered urine to
which it was added. It was also apparent that the binding affinity of ChS was very much less than that of HS;
ChS was only detectable in the crystals when its concentration in the ultrafiltered urine was 10 µg/ml, in contrast to HS, which was visible in crystals generated in
the presence of a concentration of 2 µg/ml. The relative
binding affinities of ChS and HS in undiluted urine are
therefore the same as those reported for inorganic solutions [l, 10). The present studies also demonstrated that
ChS can bind to CaOx crystals and become included into
crystals precipitated from urine. The fact that this only
occurs in the absence of HS suggests that HS and ChS
compete for the same binding sites on the crystal surfaces. Since evidence would indicate that HS may fulfil
an inhibitory role in CaOx stone pathogenesis, as discussed above, it is attractive to speculate that in vivo
ChS may compensate for a deficiency of HS in the
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S. Nishio: The present study showed that heparan sulfate was selectively included into calcium oxalate crystals in the presence of both heparan sulfate and chondroitin sulfate. Did you examine the influence of urinary
pH?
Authors: No, we did not examine the influence of pH.
All urines were used at their native pH.

33. Wiggins RC (1987). Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physiochemical
conditions. Clin Chim Acta 162: 329-340.
34. Yamaguchi S, Yoshioka T, Utsonomiya M,
Koide T, Osafune M, Okuyama A, Sonoda T (1993).
Heparan sulfate in the stone matrix and its inhibitory
effect on calcium oxalate crystallization. Urol Res 21:
187-192.

J.P. Binette: Papain digestion, had it displaced the HS
band, would have complicated matters and cannot exclude the peptide moiety in this system. Why were
GAGs not expected from CaOx crystals deposited from
UF urines?
Authors: Had the HS band been altered after heparitinas treatment, it might have indicated that the binding
affinity of HS for the crystal surface was dependent
upon its being linked to a protein moiety. GAGs were
not expected from crystals precipitated from ultrafiltered
urine because all macromolecules with molecular mass
> 10 kDa were removed by the ultrafiltration process.

Discussion with Reviewers
S. Yamaguchi: In general, both glycosaminoglycans
and urinary proteins adsorb on CaOx crystals in whole
urine. Do these proteins and heparan sulphate compete
for the same binding sites on the crystals?
Authors: We have not performed competitive binding
studies between GAGs and proteins and so cannot provide a definite answer to this question. However, even
if they do compete, it is apparent that binding of neither
type of macromolecule completely prohibits adsorption
of the other, since the organic matrix of calcium oxalate
crystals precipitated from whole urine, contains both HS
(as shown in this paper) and proteins (as shown in reference 9). This could suggest that HS and proteins do not
compete for the same binding sites on the crystals. Alternatively however, it is possible that either HS or proteins could first be adsorbed in the early stages of crystallization, but that subsequent deposition of CaOx is
sufficient to bind the other in the later stages of crystal
growth.

J.P. Binette: ChS is detected in the matrix of some
stones. The statement that GAGs are a product of the
calculus is succinct and incorrect. GAGs maybe dislodged from tissue by sharp crystals or aggregates to
which they may bind and thus rejoin the formation of
the calculus.
Authors: I am aware of no study that has conclusively
demonstrated the presence of ChS in calcium oxalate
stone matrix, although it has been detected in magnesium ammonium phosphate stones [19] and is present in
small amounts in apatite calculi [16]. The statement that
there are two possible mechanisms of GAGs inclusion
into the matrix of stones may well be succinct, but it is
not incorrect. In fact, Dr. Binette's remark that GAGs
"may be dislodged from tissue by sharp crystals or aggregates to which they may bind and thus rejoin the formation of the calculus" completely supports the argument. Normal urinary GAGs may be present in crystals/stones because they have been involved in the crystallization process: they are forerunners to nucleation.
On the other hand, GAGs not normally present in urine,
but which are released by tissue injury caused by crystals or the growing stone, may also then bind to the
crystals and become part of the final stone structure,
these GAGs are products of the developing stone which
later become part of the final urolith.

S. Yamaguchi: What do you think of the selective incorporation of heparan sulphate into CaOx crystals? Is
it simple incorporation or specific incorporation?
Authors: The fact that HS is incorporated into CaOx
crystal matrix is evidence that the GAG binds to the
crystal surface, but whether this binding is simple (nonspecific) or occurs at specific sites cannot be stated with
certainty from our data. Nonetheless, the fact that HS
is incorporated to the exclusion of ChS, suggests that the
process is competitive, and this in tum implies that the
binding is specific, rather than indiscriminate.
S.R. Khan: Since crystalluria is common in both stone
formers and non-stone formers, why do you consider
crystallization a critical event in stone formation?
Authors: In so far as stone formation can never occur
without crystal nucleation, this event may be regarded as
the critical step in the crystallization process . That is
not to say, of course, that subsequent steps are not also
crucial; there is good evidence that the process of crystal
aggregation is also vital in determining whether or not
crystalluria will proceed to stone formation.
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